AAV-gene therapy (GenSight Biologics)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV-gene therapy (GenSight Biologics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUsher Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGensight Biologics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGensight Biologics
Active IndicationsN/A
Inactive IndicationsUsher Syndromes

Other Information

ATC CodeN/A
Related LinksN/A